A qualitative study of frontline US clinical trial researchers found that universal messaging, community trust-building, and stigma-aware outreach can strengthen recruitment for future HIV vaccine trials. The report emphasizes the role of communication strategy and trusted intermediaries in moving potential participants past concerns shaped by stigma. The findings are operational rather than biomedical, offering practical levers for trial sponsors and sites preparing for next-generation HIV vaccine efforts. For industry leaders, the study highlights that recruitment execution is an evidence-driven component of trial readiness—not a secondary administrative task.